Aba Chemicals Corp (300261) - Total Assets
Based on the latest financial reports, Aba Chemicals Corp (300261) holds total assets worth CN¥4.06 Billion CNY (≈ $593.74 Million USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Check Aba Chemicals Corp cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Aba Chemicals Corp - Total Assets Trend (2008–2025)
This chart illustrates how Aba Chemicals Corp's total assets have evolved over time, based on quarterly financial data. Explore how much of Aba Chemicals Corp's assets are long-term investments to see how much of total assets are deployed in long-term investments.
Aba Chemicals Corp - Asset Composition Analysis
Current Asset Composition (December 2025)
Aba Chemicals Corp's total assets of CN¥4.06 Billion consist of 36.2% current assets and 63.8% non-current assets.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 5.9% |
| Accounts Receivable | CN¥500.44 Million | 12.9% |
| Inventory | CN¥462.29 Million | 12.0% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥215.09 Million | 5.6% |
| Goodwill | CN¥214.42 Million | 5.5% |
Asset Composition Trend (2008–2025)
This chart illustrates how Aba Chemicals Corp's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Aba Chemicals Corp (300261) total market value.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Aba Chemicals Corp's current assets represent 36.2% of total assets in 2025, a decrease from 49.1% in 2008.
- Cash Position: Cash and equivalents constituted 5.9% of total assets in 2025, up from 2.5% in 2008.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 10.0% of total assets, an increase from 8.0% in 2008.
- Asset Diversification: The largest asset category is accounts receivable at 12.9% of total assets.
Aba Chemicals Corp Competitors by Total Assets
Key competitors of Aba Chemicals Corp based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Guizhou Redstar Developing Co Ltd
SHG:600367
|
China | CN¥3.34 Billion |
|
Shenzhen Dynanonic Co Ltd
SHE:300769
|
China | CN¥18.60 Billion |
|
Zhejiang Sanmei Chemical Industry Co Ltd
SHG:603379
|
China | CN¥9.36 Billion |
|
Guangdong Rongtai Industry Co Ltd
SHG:600589
|
China | CN¥3.63 Billion |
|
Jingsu Jingshen Salt&Chem
SHG:603299
|
China | CN¥13.88 Billion |
|
Anhui Hwasu Co.Ltd.
SHG:600935
|
China | CN¥9.87 Billion |
|
Shanghai Chlor-Alkali Chemical Co Ltd A
SHG:600618
|
China | CN¥14.24 Billion |
|
Inner Mongolia Lantai Industrial Co Ltd
SHG:600328
|
China | CN¥25.24 Billion |
Aba Chemicals Corp - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.85 | 0.96 | 1.35 |
| Quick Ratio | 0.63 | 0.68 | 1.04 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥-277.09 Million | CN¥-56.19 Million | CN¥470.13 Million |
Aba Chemicals Corp - Advanced Valuation Insights
This section examines the relationship between Aba Chemicals Corp's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.52 |
| Latest Market Cap to Assets Ratio | 0.17 |
| Asset Growth Rate (YoY) | -3.7% |
| Total Assets | CN¥3.87 Billion |
| Market Capitalization | $648.43 Million USD |
Valuation Analysis
Below Book Valuation: The market values Aba Chemicals Corp's assets below their book value (0.17x), which may indicate investor concerns about asset quality or future growth.
Slight Asset Contraction: Aba Chemicals Corp's assets decreased by 3.7% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for Aba Chemicals Corp (2008–2025)
The table below shows the annual total assets of Aba Chemicals Corp from 2008 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | CN¥3.87 Billion ≈ $566.08 Million |
-3.75% |
| 2024-12-31 | CN¥4.02 Billion ≈ $588.13 Million |
-3.04% |
| 2023-12-31 | CN¥4.15 Billion ≈ $606.58 Million |
+3.41% |
| 2022-12-31 | CN¥4.01 Billion ≈ $586.56 Million |
+5.32% |
| 2021-12-31 | CN¥3.81 Billion ≈ $556.94 Million |
-3.97% |
| 2020-12-31 | CN¥3.96 Billion ≈ $579.96 Million |
+10.74% |
| 2019-12-31 | CN¥3.58 Billion ≈ $523.73 Million |
-1.52% |
| 2018-12-31 | CN¥3.63 Billion ≈ $531.84 Million |
+14.14% |
| 2017-12-31 | CN¥3.18 Billion ≈ $465.95 Million |
+68.00% |
| 2016-12-31 | CN¥1.90 Billion ≈ $277.36 Million |
+20.06% |
| 2015-12-31 | CN¥1.58 Billion ≈ $231.02 Million |
+20.31% |
| 2014-12-31 | CN¥1.31 Billion ≈ $192.03 Million |
+48.01% |
| 2013-12-31 | CN¥886.62 Million ≈ $129.74 Million |
+33.81% |
| 2012-12-31 | CN¥662.61 Million ≈ $96.96 Million |
+3.32% |
| 2011-12-31 | CN¥641.33 Million ≈ $93.85 Million |
+235.82% |
| 2010-12-31 | CN¥190.98 Million ≈ $27.95 Million |
+21.37% |
| 2009-12-31 | CN¥157.35 Million ≈ $23.03 Million |
+37.19% |
| 2008-12-31 | CN¥114.70 Million ≈ $16.78 Million |
-- |
About Aba Chemicals Corp
ABA Chemicals Corporation engages in the research and development, and production of plant protection, pharmaceutical intermediates, and nutritional and health products worldwide. The company offers plant protection products, such as plant growth regulator, herbicides, insecticide, and bactericide; pharmaceutical products, including pesticide and pharmaceutical intermediates; and nutrition produc… Read more